Professor of Medicine, University Colorado
Endocrinology
Dr. James M. Falko, MD
|
|
Give Review
James Falko is an expert in the field of Endocrinology. He went to The Ohio State University College of Medicine. He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". James M. Falko, MD is a published doctor as well. He has 92 publications published. The latest was: Letter: Thyrotoxic hypercalcemia, renal tubular acidosis, and pancreatitis. He is registered with Medicare and accepts Medicare payments.
Publications
- Randomized trial assessing the impact of a musculoskeletal intervention for pain before participating in a weight management program.
- DysLipidemia in South Asians living in a western community.
- Optimal management of lipids in diabetes and metabolic Syndrome.
- Effect of a weight management program on the determinants and prevalence of metabolic Syndrome.
- A systematic approach to improve lipids in coronary artery Disease patients participating in a cardiac rehabilitation program.
- Effect of a community-based weight management program on weight loss and cardiovascular Disease risk factors.
- Cardiac rehabilitation is associated With an improvement in C-reactive protein levels in both men and women With cardiovascular disease.
- Clinical profile and outcomes of Diabetic and nonDiabetic patients in cardiac rehabilitation.
- Independent effect of cardiac rehabilitation on lipids in coronary artery Disease.
- Information from your family doctor. Diabetic neuropathy.
- Evaluation and prevention of Diabetic neuropathy.
- Cardiovascular disease risk of type 2 diabetes mellitus and metabolic Syndrome: focus on aggressive management of dyslipidemia.
- Fenofibrate monOtherapy induced rhabdomyolysis.
- Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic Syndrome.
- Acute psychological stress reduces plasma triglyceride clearance.
- Unusual manifestations of cushing's Syndrome in a multiple endocrine neoplasia type I kindred.
- Metastatic pure papillary Thyroid carcinoma presenting as a toxic hot nodule.
- Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperLipidemic patients.
- Both hypoThyroidism and hyperThyroidism enhance low density lipoprotein oxidation.
- RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary Thyroid carcinoma.
- Treatment of severe familial hypertriglyceridemia during pregnancy With very-low-fat diet and n-3 fatty acids.
- Fibrosing pseudotumor of the sella and parasellar area producing Hypopituitarism and multiple cranial nerve palsies.
- The use of continuous subcutaneous octreotide infusion in brittle Type 1 diabetic patients.
- 17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism.
- Metastatic pheochromocytoma associated with multiple endocrine neoplasia Syndrome type II.
- Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent Diabetic, impaired glucose tolerant, and control populations.
- Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II Diabetes.
- Metoclopramide suppositories in the treatment of Diabetic gastroparesis.
- Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory Diabetic patients.
- Coexistence of Diabetes mellitus, optic atrophy, and sensorineural deafness: case report.
- Chronic hyponatremia associated With diabetic amyotrophy.
- Alterations in lipid and carbohydrate Metabolism attributable to cyclosporin A in renal transplant recipients.
- The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in Type 2 diabetic patients.
- Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in Type II diabetic patients.
- Premenstrual Syndrome: concerns, controversies, and treatment.
- Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma.
- Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein Metabolism and glucoregulation.
- Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperThyroidism.
- Serum C-peptide levels determine glycemic responses in Type II diabetic patients treated with combined insulin and sulfonylurea agent.
- Osteoporosis in primary care.
- Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid Metabolism.
- Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities.
- Serum lipids and lipoprotein composition in spontaneously Diabetic BB Wistar rats.
- Pregnancy complicated by insulinoma.
- Solitary cold Thyroid nodule: cost-ineffectiveness of ultrasonography.
- Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperThyroid patients.
- Significance of spontaneous ketonuria and serum C-peptide levels in obese Type II diabetic patients.
- The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects.
- Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient With malignant insulinoma.
- Primary hyperparaThyroidism: analysis of 220 patients with special emphasis on familial hypocalciuric hypercalcemia.
- Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some Type I diabetics.
- Primary Adrenal insufficiency manifesting as malignant lymphoma.
- Ocular changes in Graves' Disease.
- Hypertensive crisis induced by eating in a patient With pheochromocytoma.
- Thyrotrophin-producing pituitary adenomas.
- Serum lipoprotein responses during active and stable weight reduction in reproductive obese females.
- Spurious elevations in glycosylated hemoglobin (HbA1) Secondary to hypertriglyceridemia.
- The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose.
- Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
- "Pseudo" Renal failure after isopropyl alcohol intoxication.
- Gastrin Responses to a test meal in patients with familial medullary Thyroid carcinoma.
- The value of technetium Tc 99m pertechnetate Thyroid scanning in the diagnosis of factitious thyrotoxicosis.
- Diabetes insipidus and breast cancer.
- Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP).
- Improvement of high-density lipoprotein-cholesterol levels. Ambulatory Type I diabetics treated with the subcutaneous insulin pump.
- Thyroid uptake of Tc-99m compromising in vivo RBC tagging.
- Thyrotoxicosis and a thyrotropin-secreting pituitary Tumor causing unilateral exophthalmos.
- Arrhythmia induced by a tricyclic antidepressant in a patient With undiagnosed mitral valve prolapse.
- Metrizamide cisternography in the investigation of the empty sella Syndrome.
- Recognizing Thyroid disease in the elderly: current considerations.
- The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
- Benign parotid enlargement in bulimia.
- High density lipoprotein (HDL): a protective lipoprotein.
- Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins.
- Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins.
- Dietary treatment of Type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol.
- Effects of estrogen therapy on apolipoprotein E in Type II hyperlipoproteinemia.
- Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus.
- Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies.
- Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
- Stimulation of pancreatic secretion of water and electrolytes by furosemide.
- Hazards in antihypertension therapy.
- Inhibition of intestinal iron absorption by laundry starch.
- Letter: Thyrotoxic hypercalcemia, Renal tubular acidosis, and pancreatitis.
- Primary hyperparaThyroidism and anemia.
- The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.
- Letter: Erythrocytosis and hypoThyroidism.
- Case report. Congestive heart failure complicating the hungry bone Syndrome.
- Letter: Acute pancreatitis due to procainamide-induced lupus erythematosus.
- Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man.
- Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstruction.
Schools
Ohio State University College Of Medicine
Wash
Conditions Treated
- Abnormal Thyroid
- AdRenal Insufficiency
- Calcium Metabolism Disorders
- Cushing's Syndrome
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Ohio State University Hospital -
The Ohio State University College of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1669460887 | |
| NPPES Provider LastName | FALKO | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 923.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669460887 |
| Last Name Of The Provider | FALKO |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
Dr. Lisa Kosmiski, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryan R. Haugen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Daniel H. Bessesen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Satish K. Garg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Holly R. Wyatt, MD
This Doctor is OpenDoctor Recommended.
|